The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the world’s first low-carbon version of a triple-combination inhaler for chronic obstructive pulmonary disease (COPD). The ...
While the effectiveness of drug therapy for COPD patients at advanced stages of disease has been proven, little evidence exists regarding starting treatment at earlier stages. The findings of the ...
This article is developed and funded by Chiesi Ltd. Dr Sooj has been paid an honorarium for his author contribution. Views are the author’s own and do not represent the NHS. I’M Dr Suraj Kukadia, ...
New york, USA, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight ...
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially ...
communication features with healthcare providers. While some of these technologies also feature pulmonary rehabilitation and virtual ward components, these are not included within the scope of this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results